Research Topics
| Jay SosenkoSummaryAffiliation: University of Miami Country: USA Publications
| Collaborators
|
Detail Information
Publications
Albuminuria in recent-onset type 2 diabetes: the Strong Heart StudyJay M Sosenko
University of Miami School of Medicine, Miami, Florida, USA
Diabetes Care 25:1078-84. 2002..We have used a prospective cohort study to examine this...- The application of the diabetes prevention trial-type 1 risk score for identifying a preclinical state of type 1 diabetesJay M Sosenko
Division of Endocrinology, University of Miami, Miami, FL, USA
Diabetes Care 35:1552-5. 2012..We assessed the utility of the Diabetes Prevention Trial-Type 1 Risk Score (DPTRS) for identifying individuals who are highly likely to progress to type 1 diabetes (T1D) within 2 years... - A longitudinal study of GAD65 and ICA512 autoantibodies during the progression to type 1 diabetes in Diabetes Prevention Trial-Type 1 (DPT-1) participantsJay M Sosenko
ivision of Endocrinology, University of Miami, Miami, Florida, USA
Diabetes Care 34:2435-7. 2011..We examined changes in GAD65 and ICA-512 autoantibodies (GADA and IA-2A) during progression to type 1 diabetes (T1D)... - Validation of the Diabetes Prevention Trial-Type 1 Risk Score in the TrialNet Natural History StudyJay M Sosenko
University of Miami, Miami, FL, USA
Diabetes Care 34:1785-7. 2011..We assessed the accuracy of the Diabetes Prevention Trial-Type 1 Risk Score (DPTRS), developed from the Diabetes Prevention Trial-Type 1 (DPT-1), in the TrialNet Natural History Study (TNNHS)... - Glucose excursions between states of glycemia with progression to type 1 diabetes in the diabetes prevention trial-type 1 (DPT-1)Jay M Sosenko
Division of Endocrinology, University of Miami, Miami, Florida, USA
Diabetes 59:2386-9. 2010..We characterized fluctuations between states of glycemia in progressors to type 1 diabetes and studied whether those fluctuations are related to the early C-peptide response to oral glucose... - A comparison of the baseline metabolic profiles between Diabetes Prevention Trial-Type 1 and TrialNet Natural History Study participantsJay M Sosenko
Division of Endocrinology, University of Miami, Miami, FL, USA
Pediatr Diabetes 12:85-90. 2011..We assessed whether differing autoantibody screening criteria for type 1 diabetes (T1D) prevention trials result in different baseline metabolic profiles of those who screen positive... - Trends of earlier and later responses of C-peptide to oral glucose challenges with progression to type 1 diabetes in diabetes prevention trial-type 1 participantsJay M Sosenko
Division of Endocrinology, University of Miami, Miami, Florida, USA
Diabetes Care 33:620-5. 2010..001); peak C-peptide levels were less predictive (P < 0.05). CONCLUSIONS A decreased early C-peptide response to oral glucose and an increased later response occur at least 2 years before the diagnosis of type 1 diabetes... - The prevalence of diabetic neuropathy according to ethnicityJay M Sosenko
Diabetes Research Institute, Miami, FL 33136, USA
Curr Diab Rep 9:435-9. 2009..However, this trend is not always consistent and there is no clear explanation for it... - Incident dysglycemia and progression to type 1 diabetes among participants in the Diabetes Prevention Trial-Type 1Jay M Sosenko
Division of Endocrinology, University of Miami, Miami, Florida, USA
Diabetes Care 32:1603-7. 2009..We studied the incidence of dysglycemia and its prediction of the development of type 1 diabetes in islet cell autoantibody (ICA)-positive individuals. In addition, we assessed whether dysglycemia was sustained... - Glucose and C-peptide changes in the perionset period of type 1 diabetes in the Diabetes Prevention Trial-Type 1Jay M Sosenko
Division of Endocrinology, University of Miami, Miami, Florida, USA
Diabetes Care 31:2188-92. 2008..We examined metabolic changes in the period immediately after the diagnosis of type 1 diabetes and in the period leading up to its diagnosis in Diabetes Prevention Trial-Type 1 (DPT-1) participants... - A risk score for type 1 diabetes derived from autoantibody-positive participants in the diabetes prevention trial-type 1Jay M Sosenko
Division of Endocrinology, University of Miami, P O Box 016960 D110, Miami, FL 33101, USA
Diabetes Care 31:528-33. 2008..The accurate prediction of type 1 diabetes is essential for appropriately identifying prevention trial participants. Thus, we have developed a risk score for the prediction of type 1 diabetes... - Increasing the accuracy of oral glucose tolerance testing and extending its application to individuals with normal glucose tolerance for the prediction of type 1 diabetes: the Diabetes Prevention Trial-Type 1Jay M Sosenko
Division of Endocrinology, University of Miami, P O Box 016960 D110, Miami, FL 33101, USA
Diabetes Care 30:38-42. 2007.... - Patterns of metabolic progression to type 1 diabetes in the Diabetes Prevention Trial-Type 1Jay M Sosenko
Division of Endocrinology, University of Miami, PO Box 016960 D110, Miami, FL 33101, USA
Diabetes Care 29:643-9. 2006..The goal of this study was to utilize data from the Diabetes Prevention Trial-Type 1 (DPT-1) to obtain a picture of the metabolic progression to type 1 diabetes over a period of approximately 2.5 years before its diagnosis... - Sensory function and albumin excretion according to diagnostic criteria for diabetesJay M Sosenko
Department of Medicine, University of Miami School of Medicine, Miami, FL 33101, USA
Diabetes Care 27:1716-20. 2004..The purpose of this study was to examine sensory function and albumin excretion according to categories of glucose tolerance in individuals undergoing screening for diabetes... - The epidemiology of neuropathic foot ulcers in individuals with diabetesJay Sosenko
University of Miami, School of Medicine, P O Box 016960 R 53, Miami, FL 33101, USA
Curr Diab Rep 2:477-81. 2002.... - Unusually difficult challenges in human-subjects researchArturo Brito
P.O. Box 016960 (M-820, Miami, FL, USA
Prof Ethics 11:39-43. 2003 - Diabetic neuropathies: a statement by the American Diabetes AssociationAndrew J M Boulton
Department of Medicine, Manchester Royal Infirmary, Oxford Road, Manchester M13 9WL, U.K
Diabetes Care 28:956-62. 2005 - Diabetic somatic neuropathiesAndrew J M Boulton
Division of Endocrinology, University of Miami School of Medicine, P.O. Box 016960 (D-110, Miami, Florida, USA
Diabetes Care 27:1458-86. 2004 - Incidence of lower-extremity amputation in American Indians: the Strong Heart StudyHelaine E Resnick
Department of Epidemiology and Statistics, MedStar Research Institute, 6495 New Hampshire Ave, Suite 201, Hyattsville, MD 20783, USA
Diabetes Care 27:1885-91. 2004..To define incidence and predictors of nontraumatic lower-extremity amputation (LEA) in a diverse cohort of American Indians with diabetes...